HealthEquity, Inc. (NASDAQ:HQY) Shares Acquired by Radnor Capital Management LLC

Radnor Capital Management LLC raised its stake in shares of HealthEquity, Inc. (NASDAQ:HQY) by 6.2% in the first quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 6,040 shares of the company’s stock after acquiring an additional 350 shares during the period. Radnor Capital Management LLC’s holdings in HealthEquity were worth $534,000 as of its most recent SEC filing.

A number of other institutional investors have also made changes to their positions in HQY. Janney Montgomery Scott LLC increased its position in shares of HealthEquity by 8.5% during the fourth quarter. Janney Montgomery Scott LLC now owns 5,352 shares of the company’s stock valued at $514,000 after acquiring an additional 420 shares during the last quarter. Entropy Technologies LP acquired a new position in shares of HealthEquity in the fourth quarter valued at approximately $224,000. Peterson Wealth Services grew its holdings in shares of HealthEquity by 5.1% in the fourth quarter. Peterson Wealth Services now owns 10,507 shares of the company’s stock valued at $1,008,000 after purchasing an additional 509 shares in the last quarter. Louisiana State Employees Retirement System grew its holdings in shares of HealthEquity by 0.4% in the fourth quarter. Louisiana State Employees Retirement System now owns 24,200 shares of the company’s stock valued at $2,322,000 after purchasing an additional 100 shares in the last quarter. Finally, Legato Capital Management LLC acquired a new position in shares of HealthEquity in the fourth quarter valued at approximately $778,000. 99.55% of the stock is currently owned by institutional investors and hedge funds.

Analyst Ratings Changes

A number of research analysts recently weighed in on the stock. Barrington Research lifted their price objective on shares of HealthEquity from $112.00 to $125.00 and gave the company an “outperform” rating in a report on Thursday. Bank of America lifted their price objective on shares of HealthEquity from $110.00 to $125.00 and gave the company a “buy” rating in a report on Wednesday. KeyCorp dropped their price objective on shares of HealthEquity from $110.00 to $100.00 and set an “overweight” rating for the company in a report on Wednesday, April 16th. Raymond James upgraded shares of HealthEquity from an “outperform” rating to a “strong-buy” rating and dropped their price objective for the company from $120.00 to $115.00 in a report on Tuesday, March 25th. Finally, Wells Fargo & Company lifted their price objective on shares of HealthEquity from $110.00 to $125.00 and gave the company an “overweight” rating in a report on Wednesday, February 26th. One analyst has rated the stock with a hold rating, ten have given a buy rating and one has issued a strong buy rating to the stock. According to data from MarketBeat, HealthEquity currently has a consensus rating of “Buy” and an average price target of $118.09.

HealthEquity Stock Down 1.0%

Shares of HealthEquity stock opened at $111.55 on Friday. HealthEquity, Inc. has a 52-week low of $65.01 and a 52-week high of $116.65. The company has a 50 day moving average of $91.48 and a 200 day moving average of $97.77. The company has a quick ratio of 3.20, a current ratio of 3.20 and a debt-to-equity ratio of 0.51. The company has a market capitalization of $9.65 billion, a P/E ratio of 102.34, a P/E/G ratio of 1.60 and a beta of 0.45.

HealthEquity (NASDAQ:HQY) last issued its quarterly earnings results on Tuesday, June 3rd. The company reported $0.97 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.81 by $0.16. HealthEquity had a net margin of 8.41% and a return on equity of 9.70%. The company had revenue of $330.80 million during the quarter, compared to the consensus estimate of $322.25 million. During the same quarter in the previous year, the firm earned $0.80 earnings per share. As a group, research analysts forecast that HealthEquity, Inc. will post 2.32 EPS for the current fiscal year.

Insider Transactions at HealthEquity

In other news, EVP Michael Henry Fiore sold 8,881 shares of the business’s stock in a transaction that occurred on Friday, April 4th. The shares were sold at an average price of $78.26, for a total transaction of $695,027.06. Following the completion of the sale, the executive vice president now owns 56,655 shares in the company, valued at approximately $4,433,820.30. The trade was a 13.55% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. Also, Director Robert W. Selander sold 5,750 shares of the business’s stock in a transaction that occurred on Wednesday, April 9th. The stock was sold at an average price of $77.65, for a total transaction of $446,487.50. Following the sale, the director now owns 84,969 shares of the company’s stock, valued at $6,597,842.85. This represents a 6.34% decrease in their position. The disclosure for this sale can be found here. Insiders own 1.50% of the company’s stock.

HealthEquity Profile

HealthEquity, Inc provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, receive personalized benefit information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.